← Back to catalogue
Published

Kashin–Beck disease

vr.tr.kashin-beck-disease · thing-q500314

Enable an agent to recognise Kashin-Beck disease, assess its growth and joint consequences, and support evidence-based diagnostic, surveillance and care decisions.

Thing Registry Cross-cutting context XCT.STA

Bundle → Layer → Finding → Questions Filled

6 bundles · 11 layers · 17 findings · 29 questions

Recognition and diagnostic boundaries Determine what evidence supports identifying this endemic osteoarticular condition.

Clinical and radiographic concordance

Connect examination findings with age-appropriate skeletal imaging.

Concordant osteoarticular pattern

Record symptoms, movement restriction, deformity and imaging findings separately before assessing agreement; published research has used explicit clinical case definitions. [Tibetan population study](https://www.nejm.org/doi/full/10.1056/NEJM199810153391604).

  1. Which joints and skeletal regions show abnormalities, and how do examination and imaging agree? measurement
  2. Which findings could instead be explained by trauma, inflammatory arthritis or another skeletal disorder? boundary

Criteria and concept mapping

Bind the diagnosis to a named standard and the intended disease concept.

Versioned case assertion

Retain the issuing body, revision, applicable population and supporting observations for each diagnosis; resolve terminology mappings independently of the clinical decision.

  1. Which issuing body and exact criteria revision support this diagnostic assertion? provenance
  2. Which verified ICD-10, ICD-11 and SNOMED CT mappings identify this concept in the required editions? definition
  3. Is this record a suspected case, an established diagnosis or only a screening observation? boundary
Skeletal course and disability Describe growth-related damage and subsequent joint consequences over time.

Growth and developmental damage

Relate skeletal abnormalities to the period of growth.

Developmental trajectory

Record onset estimates, serial growth and metaphyseal or epiphyseal observations without inferring childhood onset solely from adult deformity.

  1. What evidence dates symptom onset and skeletal abnormalities relative to growth and skeletal maturity? provenance
  2. How have height, body proportions and affected digits changed against an identified growth reference? measurement

Persistent joint burden

Separate fixed deformity, changing joint damage and functional limitation.

Structural and functional state

Record structural grade under its own standard alongside pain, mobility and participation; do not use a severity grade as proof of ongoing progression.

  1. Which dated observations demonstrate progression, stability or improvement? measurement
  2. Which walking, hand-use or daily activities are limited, and which changes warrant clinical reassessment? action
Endemic setting and causal evidence Represent exposure context while preserving uncertainty about causation.

Childhood exposure setting

Reconstruct where and when relevant exposures could have occurred.

Dated residence and supply history

Link childhood residence, food sourcing and water supply to contemporaneous local evidence rather than present-day address.

  1. Where did the person live during growth, and what evidence describes disease occurrence there during those years? provenance
  2. Which food or water exposures were measured directly, reported retrospectively or inferred from locality? boundary

Nutritional and environmental hypotheses

Distinguish measured nutritional status from proposed disease mechanisms.

Association versus causation

Keep selenium and iodine measurements separate from causal attribution; research has assessed these nutritional factors in affected Tibetan populations. [Population study](https://www.nejm.org/doi/full/10.1056/NEJM199810153391604).

  1. Which nutritional or environmental factors have direct measurements, with specimen, method, units and date? measurement
  2. Does the cited evidence establish association, an experimental effect or a causal mechanism, and what competing explanations remain? provenance
Population burden and surveillance Interpret disease occurrence by locality, cohort and ascertainment method.

Population and case definition

Make estimates reproducible and comparable.

Bounded burden estimate

Require geography, observation year, age range, numerator, denominator, sampling method and diagnostic definition for every burden estimate.

  1. What population, year and case definition produced this prevalence or incidence estimate? measurement
  2. Were cases found through clinical screening, radiography or existing records, and who was missed? provenance

Incident disease and residual burden

Distinguish new disease from longstanding cases newly detected.

Cohort-specific surveillance signal

Interpret trends using onset evidence, age cohorts and changes in screening coverage or diagnostic criteria.

  1. Does a newly reported case represent recent onset or delayed recognition of longstanding disease? boundary
  2. Could migration, ageing, screening changes or revised criteria explain the apparent trend? provenance
Prevention and care decisions Match proposed actions to disease status, functional needs and applicable evidence.

Prevention evidence

Evaluate population interventions against incident disease and skeletal outcomes.

Intervention context and endpoint

Record intervention composition, baseline nutritional status, comparator and endpoints. A Qinghai trial assessed grain replacement and selenium-iodine salt using new cases and radiographic outcomes. [Intervention trial](https://pubmed.ncbi.nlm.nih.gov/25252032/).

  1. Did the study measure prevention of new cases, change in existing lesions or correction of nutrient deficiency? boundary
  2. Which population differences, concurrent interventions and study limitations affect applicability here? action

Established disease management

Connect care options to documented impairment and realistic outcomes.

Care target and response

Separate symptom relief, functional improvement and structural change. A Tibetan trial found no added benefit of selenium for established disease after iodine correction, limiting assumptions that supplementation reverses damage. [Randomized trial](https://pubmed.ncbi.nlm.nih.gov/12816783/).

  1. Is the proposed action intended to address deficiency, pain, mobility, deformity or another explicit target? action
  2. What clinician-reviewed evidence supports rehabilitation, medication or surgical assessment for this person's impairment? provenance
  3. Which baseline and follow-up measures will establish benefit, adverse effects or need to change the care plan? measurement
Evidence and external alignment What the world already says about this thing, gathered so the model can be checked against it.

Reported evidence

Findings from the breadth pass, kept separate from the structural claims.

Check these first

Recalled without web access and unsourced; every item is a lead to verify.

  1. Which of these check these first hold for the sense of Kashin-Beck disease this model covers, and on what evidence? provenance

Identifiers and schemes

Recalled without web access and unsourced; every item is a lead to verify.

  1. Which of these identifiers and schemes hold for the sense of Kashin-Beck disease this model covers, and on what evidence? provenance

Standards and regulation

Recalled without web access and unsourced; every item is a lead to verify.

  1. Which of these standards and regulation hold for the sense of Kashin-Beck disease this model covers, and on what evidence? provenance

Real-world use

Recalled without web access and unsourced; every item is a lead to verify.

  1. Which of these real-world use hold for the sense of Kashin-Beck disease this model covers, and on what evidence? provenance

Failure modes and hazards

Recalled without web access and unsourced; every item is a lead to verify.

  1. Which of these failure modes and hazards hold for the sense of Kashin-Beck disease this model covers, and on what evidence? provenance

Regional variation

Recalled without web access and unsourced; every item is a lead to verify.

  1. Which of these regional variation hold for the sense of Kashin-Beck disease this model covers, and on what evidence? provenance

Neighbouring kinds and how to tell them apart

Recalled without web access and unsourced; every item is a lead to verify.

  1. Which of these neighbouring kinds and how to tell them apart hold for the sense of Kashin-Beck disease this model covers, and on what evidence? provenance

Classifiers Filled

Family
Thing Registry
Category
Cross-cutting context
Entry kind
thing
Plane
XCT
Domain
XCT.STA

What it is Filled

Kashin-Beck disease is an endemic, chronic osteochondropathy beginning mainly in childhood, characterized by damage and necrosis of growth-plate and articular cartilage that can cause joint enlargement, deformity, restricted movement and impaired growth.

In scope

  • Clinical and radiographic evidence of endemic osteochondropathy affecting growing bone and joints
  • Diagnostic criteria, differential diagnosis and versioned terminology mappings
  • Childhood onset, growth disturbance and persistent adult joint disability
  • Residence and exposure histories relevant to endemic disease
  • Population surveillance and evidence for prevention or management

Out of scope

  • The patient's complete identity, history and unrelated conditions
  • Appointments, admissions, billing and other episode-of-care administration
  • General models of osteoarthritis, inflammatory arthritis and skeletal dysplasia
  • Keshan disease and other cardiac conditions
  • Independent models of nutrient deficiency, grain contamination and water quality

Why it exists Filled

Enable an agent to recognise Kashin-Beck disease, assess its growth and joint consequences, and support evidence-based diagnostic, surveillance and care decisions.

Distinguishing features Filled

  • Assess the combination of developmental skeletal abnormalities and joint disease; adult joint degeneration alone does not establish Kashin-Beck disease.
  • Examine the distribution and symmetry of joint enlargement, deformity and restricted movement together with radiographs and childhood residence history.
  • Evaluate metaphyseal and epiphyseal abnormalities against the selected diagnostic standard rather than treating short stature or joint pain as specific findings.
  • Require consideration of inflammatory, traumatic, nutritional and inherited skeletal alternatives before attributing abnormalities to Kashin-Beck disease.
  • Disambiguate Kashin-Beck disease from the similarly named Keshan disease; the intended concept concerns osteoarticular disease.

What robots and AI may and may not do Filled

Must not

  • Blame affected communities or describe them in demeaning terms.
  • Present contested causes as settled.
  • Diagnose the disease in a specific child.
  • Promote supplements or remedies as cures.

Only with a human decision

  • Public health interventions such as changing diet, water or grain supplies.

May

  • Explain Kashin-Beck disease and its suspected environmental causes from reputable sources.
  • Report public health data on affected regions with dates and sources.

Moral aspects Filled

  • The disease affects poor rural communities whose environment and diet shaped their risk.
  • Children disabled young lose chances in education and work.

Who is affected

  • Children in affected regions
  • Rural communities
  • Families

Owners Filled

Steward

Nobody owns the disease; public health authorities answer for prevention programmes.

Master systems

  • Public health surveillance records

Links to other meta-models Filled

parent

  • Q3251367 - registry parent class

What else AI and robots need to interact with it Filled

Identity and identifiers required Filled

  • Vercy registry: vr.tr.kashin-beck-disease
  • Wikidata: Q500314 (https://www.wikidata.org/wiki/Q500314)

Direct properties not applicable Not applicable

  • Diagnostic assertion: Suspected, meets specified criteria, indeterminate, excluded; assessor and assessment date
  • Diagnostic standard: Issuing body, document identifier, revision, jurisdiction and applicable age group
  • Terminology mapping: Verified ICD-10, ICD-11 or SNOMED CT identifier with release, national modification or edition, and mapping precision
  • Onset and recognition ages: Years, recorded separately with uncertainty
  • Joint involvement pattern: Joint, side, symmetry, enlargement, deformity, pain and movement restriction
  • Growth consequences: Height in cm; height-for-age z score with reference; segment proportions and digit shortening
  • Radiographic phenotype: Anatomical site, metaphyseal or epiphyseal abnormality, joint change, acquisition date and reader confidence
  • Endemic exposure history: Locality and residence dates, childhood food and water sources, locality-specific evidence period
  • Functional burden: Joint range in degrees; pain and function scores with instrument; walking and hand-use limitations

Plane XCT: no invented physical properties.

Recognition optional Filled

  • Enlarged, stiff finger and other joints in children and adults.
  • Short stature and shortened limbs in severe cases.

Capabilities and actions required Filled

  • Assemble a disease-specific evidence summary for clinician review and identify missing diagnostic observations.
  • Compare a diagnostic assertion with its cited standard and flag unsupported coding or grading.
  • Track growth, joint structure and function separately across childhood and adulthood.
  • Compare geographically and temporally matched surveillance estimates using explicit case definitions.
  • Evaluate prevention and treatment evidence against the person's age, disease status and nutritional context.
  • Identify needs for specialist assessment, rehabilitation or environmental investigation without autonomously prescribing treatment.

Hazards and failure modes required Filled

  • Permanent joint deformity and disability from childhood.
  • Limited mobility affects farm work and livelihoods.

Standards and interfaces required Filled

  • The International Classification of Diseases, Tenth Revision, issued by the World Health Organization, classifies Kashin-Beck disease under code M12.1.

Context of use required Filled

  • Kashin-Beck disease is encountered in clinical assessment and public health surveillance in affected endemic regions.
  • Assessment focuses on childhood growth, joint changes, pain, mobility and lasting functional limitations.
  • Records of residence and exposure context help interpret findings alongside examination and imaging.

Sources Filled

  1. Wikidata item Q500314: Kashin–Beck disease - identity and sense of the item
  2. Wikipedia: Kashin–Beck disease - general description of the item

Open questions

  • Which diagnostic and severity standards are currently authoritative in each relevant jurisdiction, and how should childhood radiographic cases and adult residual disease be reconciled?
  • What are the exact verified ICD-10, ICD-11 and SNOMED CT mappings, including edition, national modification and site-specific coding requirements?
  • What recent locality- and age-specific surveillance data distinguish incident childhood disease from prevalent adult disability?
  • How strong is the causal evidence for selenium deficiency, iodine status, grain-associated mycotoxins and water constituents, individually and in combination?
  • Which prevention and management interventions have sufficiently robust, age-specific evidence for durable benefit, and which reported radiographic improvements predict better function?

Machine files

Provenance

thing registry research (pass 2) · unreviewed

Built from: models/things/publications/thing-q500314/spec.json